Clinical Trial

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Canada

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2025-11-18; most recent amendment 2026-07-02.
Status change: Not Yet Recruiting → Recruiting 2026-01-26
Trial Details
NCT Number NCT07249489
Lead Sponsor Nanochon, Inc.
Conditions Knee Cartilage Lesions
Enrollment 10 participants
Start Date 2026-07
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-06